Atlas Trials

Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma

Clinical trial NCT01208103 · COMPLETED

Trial details

NCT number
NCT01208103
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ampulla of Vater AdenocarcinomaSmall Intestinal AdenocarcinomaStage III Ampulla of Vater Cancer AJCC v8Stage III Small Intestinal Adenocarcinoma AJCC v8Stage IIIA Ampulla of Vater Cancer AJCC v8Stage IIIA Small Intestinal Adenocarcinoma AJCC v8Stage IIIB Ampulla of Vater Cancer AJCC v8Stage IIIB Small Intestinal Adenocarcinoma AJCC v8Stage IV Ampulla of Vater Cancer AJCC v8Stage IV Small Intestinal Adenocarcinoma AJCC v8
Start date
2011-05-06
Primary completion
2018-03-07
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.